Position in AZN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$486,820,016
New position
Shares Held
2,468,411
first reported quarter
Ownership
0.159%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Swedbank AB holds $4,916,192,999 across 10 Drug Manufacturers - General names. AZN ranks #5 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,616,304 | $1,486,627,929 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,091,711 | $853,061,915 | |
| 3 | JNJ |
Johnson & Johnson
|
2,921,146 | $714,044,927 | |
| 4 | ABBV |
AbbVie Inc.
|
2,396,920 | $521,306,130 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
2,468,411 | $486,820,016 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,398,000 | $334,209,259 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,961,679 | $179,625,830 | |
| 8 | PFE |
Pfizer Inc
|
6,150,865 | $172,716,287 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $486,820,016 | 2,468,411 | Shares | Defined | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||